What this study is
VOICE-HF is a clinical study designed to evaluate the performance of a novel non-invasive software device (Noah Labs Vox) that uses vocal characteristics to estimate DHF risk and has strong potential for clinical success. This study will compare the performance of Noah Labs Vox with the contemporary performance of commonly used weight-based remote monitoring rules and applications to determine efficacy and safety.
What's being tested
- Daily Voice Recording
Intervention · DEVICE
Patients use the mobile app daily to record voice samples and answer optional wellness and symptom-related questions. Voice recordings are analyzed by an algorithm, which extracts vocal biomechanical features. Results are not shared with clinicians and participants during the study and are analyzed retrospectively after study completion.
Study details
- Sponsor
- Noah Labs
- Conditions
- Heart Failure · Chronic Heart Failure · Chronic Heart Disease
- Enrolling
- 450 people
- Starts
- 2026-10-15
- Est. completion
- 2027-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 22 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥22
- HF diagnosis (Stage C)
- DHF event within prior 180 days
You can't join if
- Monitoring with implantable volume or pressure monitoring devices, or
- Planned cardiac surgery or major intervention (e.g., LVAD or transplant), or
- Otherwise inability or unwillingness to comply with study procedures.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openBrigham and Women's Hospital
Boston, Massachusetts, United States
- Ameesh Isath, MBBS · Contact617-732-6237aisath@bwh.harvard.edu
Recruiting
Study team
Sponsor
Noah Labs
Study ID VOICE-HF-001
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.